It has been shown that enhanced FcγRIII/CD16 activation by low-fucosylated anti-SARS-CoV-2-S IgG leads to excessive macrophage and monocyte activation, associated with severe COVID-19 disease progression38,39. Here, FCGR3A is linked to COVID-19.